Loading…
Bio Medica Laboratories (BMLL)₹148.00−3.46%Pharmaceuticals
At the end of the Jun 2026 quarter, Bio Medica Laboratories' shareholders were: promoters 67.72%, FIIs 0.29%, DIIs 2.33%, public 29.66%. 0.00% of promoter shares were pledged. It had 1,194 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2026 | |
|---|---|
| Promoters | 67.72% |
| FIIs | 0.29% |
| DIIs | 2.33% |
| Public | 29.66% |
| Promoter shares pledged | 0.00% |
| Number of shareholders | 1,194 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Mukesh Mehta | Promoter | 33.87% | — |
| Pradeep Mehta | Promoter | 33.87% | — |
| Tiger Strategies Fund -I | DII | 2.33% | — |
| RATHOD MANOJ CHHAGANLALnHUF | Public | 1.73% | — |
| Yashwant Amratlal Thakkar | Public | 1.73% | — |
| M/S PRABHAT FINANCIALnSERVICES LIMITED - PROPRIETARYnACCOUNT | Public | 1.51% | — |
| NAROLA KAILASBENnPRAKASHBHAI | Public | 1.16% | — |
Promoters held 67.72% of Bio Medica Laboratories at the end of the Jun 2026 quarter.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.29% and domestic institutions (DIIs) held 2.33%.
No. The Jun 2026 filing shows no pledged promoter shares.
Bio Medica Laboratories had 1,194 shareholders at the end of the Jun 2026 quarter.
Tiger Strategies Fund -I (DII) held 2.33% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.